Studies reject aspirin for prevention of pre-eclampsia

Three new studies have found that aspirin is of no benefit in preventing pre-eclampsia or in reducing the effects of pre-eclampsia in newborns. But despite the growing body of evidence many doctors continue to use the treatment routinely.

Reporting a randomised trial of 2539 women at high risk of pre-eclampsia, researchers from the National Institute of Child Health and Human Development in the United States said that the findings showed categorically that preventive treatment with aspirin does not work. No significant differences from placebo were found in the women, recruited …